BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Controversy of GlaxoSmithKline (GSK)'s Paxil Study Author Retires From Brown University


9/6/2012 7:48:49 AM

In the midst of an ongoing campaign to have a medical journal retract a controversial study of the Paxil antidepressant, the lead author, Martin Keller, quietly retired from his academic position at Brown University. Keller officially retired on June 30 and the next day was named an emeritus professor of psychiatry and human behavior, according to a university spokesman. The spokesman, however, declined to provide any further information on the reasons for retirement and Keller did not respond to messages for comment. Consequently it is unclear if the move is linked to the hubbub surrounding the Paxil study, which has shone an uncomfortable spotlight on Brown University and figured in the recent $3 billion settlement paid by GlaxoSmithKline (GSK) to resolve civil and criminal charges in connection with off-label promotion of several drugs, failing to report safety data and reporting false prices. The deal was announced last month, after the retirement.

Read at Pharmalot

Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->